Prezista & Foetal exposure during pregnancy

4.3%

of users reported Foetal exposure during pregnancy

43.8%

also reported Birth Defects

53.4%

are women

Birth Defects

43.8%

Severe reaction

41.9%

Hospitalization

10.5%

Death

2.9%

Life-threatening condition

1.0%

Prezista: general information

0 - 9 years

1.6%

10 - 19 years

0.5%

20 - 29 years

9.9%

30 - 39 years

19.1%

40 - 49 years

23.1%

50 - 59 years

28.9%

60 - 69 years

13.4%

70 - 79 years

3.6%